CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem

Neurology. Genetics
Andréa L BenedetAlzheimer's Disease Neuroimaging Initiative

Abstract

To verify whether CYP polymorphisms are associated with amyloid-β (Aβ) pathology across the spectrum of clinical Alzheimer disease using in vivo and postmortem data from 2 independent cohorts. A candidate-gene approach tested the association between 5 genes (28 single nucleotide polymorphisms) and Aβ load measured in vivo by the global [18F]florbetapir PET standardized uptake value ratio (SUVR) in 338 Alzheimer's Disease Neuroimaging Initiative participants. Significant results were then tested using plasma Aβ and CSF Aβ and Aβ/phosphorylated tau (Aβ/p-tau) ratio in the same cohort. The significant association was also generalized to postmortem Aβ load measurement in the Rush Religious Orders Study/Memory and Aging Project cohorts. In addition, global cognition was used as a phenotype in the analysis in both cohorts. Analysis of Aβ PET identified a variant in the CYP2C19 gene (rs4388808; p = 0.0006), in which carriers of the minor allele (MA) had a lower global SUVR. A voxel-wise analysis revealed that the variant is associated with a lower Aβ load in the frontal, inferior temporal, and posterior cingulate cortices. MA carriers also had higher CSF Aβ (p = 0.003) and Aβ/p-tau ratio (p = 0.02) but had no association with Aβ plasm...Continue Reading

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
May 11, 2001·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·R Thapliyal, G B Maru
Jul 5, 2001·Cellular and Molecular Life Sciences : CMLS·P Anzenbacher, E Anzenbacherová
Oct 31, 2002·Human Psychopharmacology·Seetal DoddTrevor R. Norman
Jan 9, 2003·The American Journal of Medicine·Janyce F RogersJoseph S Bertino
May 3, 2006·Archives of General Psychiatry·Raymond L OwnbyDavid Loewenstein
Oct 21, 2006·Neuroscience Letters·Genki IshiiKoichi Otani
Jan 31, 2007·Annals of the New York Academy of Sciences·Huaxi XuXue Zhang
May 17, 2007·Current Drug Metabolism·R P MeyerB Volk
Sep 18, 2007·Cell Biochemistry and Function·B ErcanL Tamer
Oct 22, 2008·Nutrition & Metabolism·Zakia Bibi
Jun 24, 2009·Prostaglandins & Other Lipid Mediators·Jeffrey J IliffNabil J Alkayed
Apr 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sébastien N GiraudArnaud B Nicot
Oct 12, 2010·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Zhiye Chen, Lin Ma
Sep 29, 2011·Prostaglandins & Other Lipid Mediators·Christina WestphalWolf-Hagen Schunck
Apr 5, 2012·Current Alzheimer Research·David A BennettRobert S Wilson
Apr 5, 2012·Current Alzheimer Research·David A BennettRobert S Wilson
Dec 4, 2012·Journal of Psychiatry & Neuroscience : JPN·Sharon Miksys, Rachel F Tyndale
Feb 20, 2013·Molecular Psychiatry·V K RamananUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
May 16, 2014·Science Translational Medicine·Yvette I ShelineJohn R Cirrito
Dec 17, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Iris M Booth DepazElizabeth M J Gillam
Jul 22, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Andrew J SaykinUNKNOWN Alzheimer's Disease Neuroimaging Initiative
May 19, 2017·Nature Reviews. Neuroscience·Kassandra KislerBerislav V Zlokovic

❮ Previous
Next ❯

Citations

Jun 6, 2018·Journal of Alzheimer's Disease : JAD·David A BennettJulie A Schneider
Aug 24, 2021·Journal of Alzheimer's Disease : JAD·Federica CioffiKerensa Broersen

❮ Previous
Next ❯

Software Mentioned

RMINC
PLINK
R

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

© 2022 Meta ULC. All rights reserved